Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.833694
Abstract: Acute myeloid leukemia (AML) is one of the most aggressive hematopoietic malignancies. Patients still suffer from refractory/relapsed disease after anthracycline-based therapy, which leads to a poor prognosis. N6-Methyladenosine (m6A) is the most abundant post-transcriptional modification…
read more here.
Keywords:
m6a;
modification;
hl60 adr;
adriamycin resistant ... See more keywords